article thumbnail

Disaster preparedness, What we have learned from COVID 19 pandemic [COVID-19]

Annals of Family Medicine

Context: Despite a joint recommendation in 2003 by the AAMC and CDC that bioterrorism and mass-casualty training be included in the medical school curriculum, few medical schools have incorporated formal disaster training. Only 15% (n=5) received emergency response training outside of residency, with 3% (n=1) during medical school.

article thumbnail

For shared decision-making, telemedicine may be as effective as in-person appointments

Medical Xpress

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as an "article in press" in the Journal of the American College of Surgeons and presented at the Southern Surgical Association 134th Annual Meeting (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Role of General Practitioners in Acute Case Handling

Physician's Weekly

Expectations ranged from seeking reassurance and diagnostic testing to requests for medical leave. Investigators concluded that patient fears and uncertainties driving urgent GP visits were varied and understandable and could have been addressed through early educational efforts and telemedicine services.

article thumbnail

JOIN HP&M FOR A WEBINAR: “The ‘End’ of the COVID-19 Emergency: The Ryan Haight Act, Telemedicine, and Next Steps?” on Thursday, March 23, 2023 at 12 Noon EST

FDA Law Blog

By almost all accounts, these exemptions also improved prescribing and dispensing of medication to patients that need them. We will discuss the state of relevant laws prior to our new “COVID reality” and telemedicine issues during and post-pandemic, both with respect to the prescribing of controlled substances and non-controlled drugs.

article thumbnail

CONTINUED AGAIN: DEA Announces A Second Extension of its “Temporary Rule” Addressing Telemedicine Flexibilities After the End of the COVID-19 Pandemic Emergency

FDA Law Blog

Palmer — On Friday, October 6, 2023, DEA announced a second extension of telemedicine flexibilities concerning the prescribing of controlled substances, which were originally set to expire after the end of the COVID-19 pandemic emergency. HPM’s Presentation Deck and recording of the presentation are here, and here (passcode Bv3*o^i5).

article thumbnail

Growing together: How Sound creates a culture of leadership

Sound Physicians

Emerging Leaders Dr. Charles Charman, medical director and overseer of the Emerging Leaders program, presents at the 2024 EmLe cohort session at MDS. Enter the associate medical director. This unique leadership role provides another layer of leadership to support the medical director and even act as chief in their absence.

article thumbnail

TO BE CONTINUED (!?): DEA Announces It is Issuing a “Temporary Rule” to Address Telemedicine Flexibilities After the End of the COVID-19 Pandemic Emergency

FDA Law Blog

Palmer — On May 3, 2023, DEA’s Administrator Anne Milgram issued a very brief and lightly publicized statement announcing that DEA intends to issue a “temporary rule” extending telemedicine flexibilities that existed during the COVID-19 Emergency Declaration, which Declaration is set to expire on May 11, 2023.